annual D&A:
$18.59M+$6.10M(+48.84%)Summary
- As of today (May 29, 2025), ARWR annual depreciation & amortization is $18.59 million, with the most recent change of +$6.10 million (+48.84%) on September 30, 2024.
- During the last 3 years, ARWR annual D&A has risen by +$10.33 million (+124.93%).
- ARWR annual D&A is now at all-time high.
Performance
ARWR Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$6.08M+$849.00K(+16.22%)Summary
- As of today (May 29, 2025), ARWR quarterly depreciation & amortization is $6.08 million, with the most recent change of +$849.00 thousand (+16.22%) on March 31, 2025.
- Over the past year, ARWR quarterly D&A has increased by +$1.56 million (+34.45%).
- ARWR quarterly D&A is now at all-time high.
Performance
ARWR quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$21.13M+$1.56M(+7.97%)Summary
- As of today (May 29, 2025), ARWR TTM depreciation & amortization is $21.13 million, with the most recent change of +$1.56 million (+7.97%) on March 31, 2025.
- Over the past year, ARWR TTM D&A has increased by +$5.20 million (+32.68%).
- ARWR TTM D&A is now at all-time high.
Performance
ARWR TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ARWR Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.8% | +34.5% | +32.7% |
| 3 y3 years | +124.9% | +134.5% | +118.5% |
| 5 y5 years | +318.9% | +343.4% | +347.8% |
ARWR Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +124.9% | at high | +134.5% | at high | +118.5% |
| 5 y | 5-year | at high | +318.9% | at high | +343.4% | at high | +347.8% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
ARWR Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $6.08M(+16.2%) | $21.13M(+8.0%) |
| Dec 2024 | - | $5.24M(+4.2%) | $19.57M(+5.2%) |
| Sep 2024 | $18.59M(+48.8%) | $5.03M(+5.1%) | $18.59M(+6.7%) |
| Jun 2024 | - | $4.78M(+5.7%) | $17.43M(+9.5%) |
| Mar 2024 | - | $4.53M(+6.1%) | $15.92M(+13.2%) |
| Dec 2023 | - | $4.26M(+10.5%) | $14.07M(+12.6%) |
| Sep 2023 | $12.49M(+19.9%) | $3.86M(+17.8%) | $12.49M(+10.6%) |
| Jun 2023 | - | $3.28M(+22.7%) | $11.29M(+6.4%) |
| Mar 2023 | - | $2.67M(-0.7%) | $10.61M(+0.7%) |
| Dec 2022 | - | $2.69M(+1.1%) | $10.54M(+1.1%) |
| Sep 2022 | $10.42M(+26.1%) | $2.66M(+2.5%) | $10.42M(+1.5%) |
| Jun 2022 | - | $2.59M(0.0%) | $10.27M(+6.2%) |
| Mar 2022 | - | $2.59M(+0.8%) | $9.67M(+7.5%) |
| Dec 2021 | - | $2.57M(+2.8%) | $8.99M(+8.8%) |
| Sep 2021 | $8.27M(+39.1%) | $2.50M(+25.4%) | $8.27M(+9.7%) |
| Jun 2021 | - | $2.00M(+4.1%) | $7.54M(+6.5%) |
| Mar 2021 | - | $1.92M(+3.8%) | $7.08M(+8.4%) |
| Dec 2020 | - | $1.85M(+4.2%) | $6.53M(+9.9%) |
| Sep 2020 | $5.94M(+33.9%) | $1.77M(+15.5%) | $5.94M(+13.2%) |
| Jun 2020 | - | $1.54M(+12.0%) | $5.25M(+11.3%) |
| Mar 2020 | - | $1.37M(+8.9%) | $4.72M(+4.3%) |
| Dec 2019 | - | $1.26M(+16.4%) | $4.52M(+1.9%) |
| Sep 2019 | $4.44M(-5.5%) | $1.08M(+7.9%) | $4.44M(-3.2%) |
| Jun 2019 | - | $1.00M(-14.7%) | $4.59M(-3.6%) |
| Mar 2019 | - | $1.18M(-0.1%) | $4.76M(+0.5%) |
| Dec 2018 | - | $1.18M(-4.2%) | $4.74M(+0.8%) |
| Sep 2018 | $4.70M(+0.2%) | $1.23M(+4.4%) | $4.70M(+1.6%) |
| Jun 2018 | - | $1.18M(+2.0%) | $4.63M(+0.3%) |
| Mar 2018 | - | $1.15M(+1.1%) | $4.61M(-0.7%) |
| Dec 2017 | - | $1.14M(-1.2%) | $4.65M(-0.9%) |
| Sep 2017 | $4.69M(+43.9%) | $1.15M(-0.7%) | $4.69M(+7.1%) |
| Jun 2017 | - | $1.16M(-2.1%) | $4.38M(+8.5%) |
| Mar 2017 | - | $1.19M(+0.2%) | $4.04M(+10.5%) |
| Dec 2016 | - | $1.19M(+40.5%) | $3.65M(+12.0%) |
| Sep 2016 | $3.26M(+39.5%) | $843.60K(+3.1%) | $3.26M(-0.4%) |
| Jun 2016 | - | $818.20K(+1.8%) | $3.27M(+2.4%) |
| Mar 2016 | - | $803.90K(+1.2%) | $3.19M(+12.5%) |
| Dec 2015 | - | $794.30K(-7.2%) | $2.84M(+21.6%) |
| Sep 2015 | $2.34M(+73.6%) | $855.60K(+15.5%) | $2.34M(+33.4%) |
| Jun 2015 | - | $741.10K(+64.8%) | $1.75M(+36.2%) |
| Mar 2015 | - | $449.60K(+55.0%) | $1.29M(+4.4%) |
| Dec 2014 | - | $290.00K(+7.2%) | $1.23M(-8.4%) |
| Sep 2014 | $1.35M(-23.2%) | $270.40K(-2.1%) | $1.35M(-8.7%) |
| Jun 2014 | - | $276.10K(-30.2%) | $1.47M(-10.8%) |
| Mar 2014 | - | $395.80K(-1.9%) | $1.65M(-3.1%) |
| Dec 2013 | - | $403.40K(+1.1%) | $1.71M(-2.6%) |
| Sep 2013 | $1.75M(+0.1%) | $399.00K(-12.1%) | $1.75M(-2.7%) |
| Jun 2013 | - | $454.10K(+1.2%) | $1.80M(+1.7%) |
| Mar 2013 | - | $448.80K(-0.2%) | $1.77M(+1.4%) |
| Dec 2012 | - | $449.60K(+0.5%) | $1.74M(-0.3%) |
| Sep 2012 | $1.75M | $447.20K(+5.6%) | $1.75M(+28.0%) |
| Jun 2012 | - | $423.40K(-0.1%) | $1.37M(+35.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $423.90K(-6.7%) | $1.01M(+54.5%) |
| Dec 2011 | - | $454.40K(+600.2%) | $653.60K(+143.9%) |
| Sep 2011 | $268.00K(-3.5%) | $64.90K(-2.4%) | $268.00K(-1.2%) |
| Jun 2011 | - | $66.50K(-1.9%) | $271.30K(-0.9%) |
| Mar 2011 | - | $67.80K(-1.5%) | $273.80K(+59.0%) |
| Dec 2010 | - | $68.80K(+0.9%) | $172.20K(-38.0%) |
| Sep 2010 | $277.70K(-72.1%) | $68.20K(-1.2%) | $277.70K(-32.5%) |
| Jun 2010 | - | $69.00K(-304.1%) | $411.60K(-32.3%) |
| Mar 2010 | - | -$33.80K(-119.4%) | $608.30K(-31.0%) |
| Dec 2009 | - | $174.30K(-13.8%) | $881.60K(-11.4%) |
| Sep 2009 | $994.60K(-12.2%) | $202.10K(-23.9%) | $994.70K(-7.6%) |
| Jun 2009 | - | $265.70K(+10.9%) | $1.08M(-0.1%) |
| Mar 2009 | - | $239.50K(-16.7%) | $1.08M(-5.1%) |
| Dec 2008 | - | $287.40K(+1.3%) | $1.14M(+0.2%) |
| Sep 2008 | $1.13M(+12.9%) | $283.60K(+6.2%) | $1.13M(-0.2%) |
| Jun 2008 | - | $267.00K(-10.3%) | $1.14M(+1.3%) |
| Mar 2008 | - | $297.50K(+4.3%) | $1.12M(+6.0%) |
| Dec 2007 | - | $285.20K(-0.3%) | $1.06M(+5.4%) |
| Sep 2007 | $1.00M(+13.2%) | $286.20K(+13.3%) | $1.00M(+3.5%) |
| Jun 2007 | - | $252.60K(+7.7%) | $969.80K(+2.4%) |
| Mar 2007 | - | $234.50K(+1.7%) | $946.70K(+6.5%) |
| Dec 2006 | - | $230.60K(-8.5%) | $889.10K(+0.2%) |
| Sep 2006 | $887.00K(+37.7%) | $252.10K(+9.8%) | $887.00K(+1.6%) |
| Jun 2006 | - | $229.50K(+29.7%) | $873.00K(+9.9%) |
| Mar 2006 | - | $176.90K(-22.6%) | $794.50K(+3.8%) |
| Dec 2005 | - | $228.50K(-4.0%) | $765.10K(+18.8%) |
| Sep 2005 | $644.00K(+762.1%) | $238.10K(+57.7%) | $644.00K(+34.6%) |
| Jun 2005 | - | $151.00K(+2.4%) | $478.40K(+45.4%) |
| Mar 2005 | - | $147.50K(+37.3%) | $329.10K(+80.9%) |
| Dec 2004 | - | $107.40K(+48.1%) | $181.90K(+143.5%) |
| Sep 2004 | $74.70K(>+9900.0%) | $72.50K(+4164.7%) | $74.70K(-2767.9%) |
| Jun 2004 | - | $1700.00(+466.7%) | -$2800.00(0.0%) |
| Mar 2004 | - | $300.00(+50.0%) | -$2800.00(+100.0%) |
| Dec 2003 | - | $200.00(-104.0%) | -$1400.00(-1500.0%) |
| Sep 2003 | $100.00(-98.9%) | -$5000.00(-394.1%) | $100.00(-98.9%) |
| Jun 2003 | - | $1700.00(0.0%) | $9100.00(-26.6%) |
| Mar 2003 | - | $1700.00(0.0%) | $12.40K(+14.8%) |
| Dec 2002 | - | $1700.00(-57.5%) | $10.80K(+18.7%) |
| Sep 2002 | $9100.00(+160.0%) | $4000.00(-20.0%) | $9100.00(+102.2%) |
| Jun 2002 | - | $5000.00(+4900.0%) | $4500.00(-1000.0%) |
| Mar 2002 | - | $100.00(>+9900.0%) | -$500.00(-141.7%) |
| Dec 2001 | - | $0.00(-100.0%) | $1200.00(-65.7%) |
| Sep 2001 | $3500.00(-53.9%) | -$600.00(<-9900.0%) | $3500.00(-36.4%) |
| Jun 2001 | - | $0.00(-100.0%) | $5500.00(-27.6%) |
| Mar 2001 | - | $1800.00(-21.7%) | $7600.00(-3.8%) |
| Dec 2000 | - | $2300.00(+64.3%) | $7900.00(+2.6%) |
| Sep 2000 | $7600.00(-6.2%) | $1400.00(-33.3%) | $7700.00(+22.2%) |
| Jun 2000 | - | $2100.00(0.0%) | $6300.00(+50.0%) |
| Mar 2000 | - | $2100.00(0.0%) | $4200.00(+100.0%) |
| Dec 1999 | - | $2100.00 | $2100.00 |
| Sep 1999 | $8100.00(-12.0%) | - | - |
| Sep 1998 | $9200.00(-91.1%) | - | - |
| Sep 1997 | $103.80K | - | - |
FAQ
- What is Arrowhead Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual D&A year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly D&A year-on-year change?
- What is Arrowhead Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals TTM D&A year-on-year change?
What is Arrowhead Pharmaceuticals annual depreciation & amortization?
The current annual D&A of ARWR is $18.59M
What is the all time high annual D&A for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual depreciation & amortization is $18.59M
What is Arrowhead Pharmaceuticals annual D&A year-on-year change?
Over the past year, ARWR annual depreciation & amortization has changed by +$6.10M (+48.84%)
What is Arrowhead Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of ARWR is $6.08M
What is the all time high quarterly D&A for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly depreciation & amortization is $6.08M
What is Arrowhead Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, ARWR quarterly depreciation & amortization has changed by +$1.56M (+34.45%)
What is Arrowhead Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of ARWR is $21.13M
What is the all time high TTM D&A for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high TTM depreciation & amortization is $21.13M
What is Arrowhead Pharmaceuticals TTM D&A year-on-year change?
Over the past year, ARWR TTM depreciation & amortization has changed by +$5.20M (+32.68%)